Established as a spin-out from the University of Oxford, Brainomix is leading UK software company specialising in creation of AI-powered imaging biomarkers to enable precision medicine for better treatment decisions and operating globally.

Brainomix software is:

Clinically validated.
Available in over 30+ countries.
Mentioned in 50+ Clinical publications.
A patient is scanned using Brainomix's software every 5 minutes.

What we offer

Brainomix software can be used for the detection of:

- Stroke
- Interstitial Lung Disease
- Tumor assessment for clinical trials.

The Brainomix360 stroke platform utilises AI algorithms to provide real-time interpretation of brain scans, aiding doctors in treatment and transfer decisions for stroke patients. Brainomix's proprietary software generates critical information from brain scans, expanding access to life-saving stroke treatments and improving treatment rates. This ensures patients receive timely and appropriate care.

In the UK, the system reduced door in and out time from 140 to 79 minutes cutting lifesaving time off one of the most time sensitive diagnoses in medicine

What we look for

Hospital Groups, University Institutions and Research Groups.

AI

Healthtech

Immersive Technology

Medical Devices, Technology